429 related articles for article (PubMed ID: 28445971)
1. STAT3 regulates glycolysis via targeting hexokinase 2 in hepatocellular carcinoma cells.
Li M; Jin R; Wang W; Zhang T; Sang J; Li N; Han Q; Zhao W; Li C; Liu Z
Oncotarget; 2017 Apr; 8(15):24777-24784. PubMed ID: 28445971
[TBL] [Abstract][Full Text] [Related]
2. Quercetin Inhibits the Proliferation of Glycolysis-Addicted HCC Cells by Reducing Hexokinase 2 and Akt-mTOR Pathway.
Wu H; Pan L; Gao C; Xu H; Li Y; Zhang L; Ma L; Meng L; Sun X; Qin H
Molecules; 2019 May; 24(10):. PubMed ID: 31137633
[TBL] [Abstract][Full Text] [Related]
3. Caveolin enhances hepatocellular carcinoma cell metabolism, migration, and invasion in vitro via a hexokinase 2-dependent mechanism.
Chai F; Li Y; Liu K; Li Q; Sun H
J Cell Physiol; 2019 Feb; 234(2):1937-1946. PubMed ID: 30144070
[TBL] [Abstract][Full Text] [Related]
4. [miR-181c inhibits glycolysis by targeting hexokinase 2 in cancer-associated fibroblasts].
Lan H; Luo L; Qi X; Gong Y; Chen Y
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Nov; 35(11):1619-23. PubMed ID: 26607087
[TBL] [Abstract][Full Text] [Related]
5. ZMYND8 promotes the growth and metastasis of hepatocellular carcinoma by promoting HK2-mediated glycolysis.
Dou C; Mo H; Chen T; Liu J; Zeng Y; Li S; Guo C; Zhang C
Pathol Res Pract; 2021 Mar; 219():153345. PubMed ID: 33517164
[TBL] [Abstract][Full Text] [Related]
6. Antitumor Effect of Morusin via G1 Arrest and Antiglycolysis by AMPK Activation in Hepatocellular Cancer.
Cho AR; Park WY; Lee HJ; Sim DY; Im E; Park JE; Ahn CH; Shim BS; Kim SH
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638959
[TBL] [Abstract][Full Text] [Related]
7. Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin.
DeWaal D; Nogueira V; Terry AR; Patra KC; Jeon SM; Guzman G; Au J; Long CP; Antoniewicz MR; Hay N
Nat Commun; 2018 Jan; 9(1):446. PubMed ID: 29386513
[TBL] [Abstract][Full Text] [Related]
8. Butein Inhibited In Vitro Hexokinase-2-Mediated Tumor Glycolysis in Hepatocellular Carcinoma by Blocking Epidermal Growth Factor Receptor (EGFR).
Liao W; Liu J; Zhang D; Huang W; Chen R
Med Sci Monit; 2018 May; 24():3283-3292. PubMed ID: 29777095
[TBL] [Abstract][Full Text] [Related]
9. By reducing hexokinase 2, resveratrol induces apoptosis in HCC cells addicted to aerobic glycolysis and inhibits tumor growth in mice.
Dai W; Wang F; Lu J; Xia Y; He L; Chen K; Li J; Li S; Liu T; Zheng Y; Wang J; Lu W; Zhou Y; Yin Q; Abudumijiti H; Chen R; Zhang R; Zhou L; Zhou Z; Zhu R; Yang J; Wang C; Zhang H; Zhou Y; Xu L; Guo C
Oncotarget; 2015 May; 6(15):13703-17. PubMed ID: 25938543
[TBL] [Abstract][Full Text] [Related]
10. Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1α-dependent and -independent mechanism.
Wan X; Liu Y; Zhao Y; Sun X; Fan D; Guo L
PLoS One; 2017; 12(9):e0184213. PubMed ID: 28886081
[TBL] [Abstract][Full Text] [Related]
11. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
[TBL] [Abstract][Full Text] [Related]
12. Effects of orexin A on glucose metabolism in human hepatocellular carcinoma in vitro via PI3K/Akt/mTOR-dependent and -independent mechanism.
Liu Y; Zhao Y; Guo L
Mol Cell Endocrinol; 2016 Jan; 420():208-16. PubMed ID: 26549689
[TBL] [Abstract][Full Text] [Related]
13. Androgen Receptor Stimulates Hexokinase 2 and Induces Glycolysis by PKA/CREB Signaling in Hepatocellular Carcinoma.
Sun RF; Zhao CY; Chen S; Yu W; Zhou MM; Gao CR
Dig Dis Sci; 2021 Mar; 66(3):802-813. PubMed ID: 32274668
[TBL] [Abstract][Full Text] [Related]
14. Effects of mTOR-STAT3 on the migration and invasion abilities of hepatoma cell and mTOR-STAT3 expression in liver cancer.
Pu X; Guo QX; Long HA; Yang CW
Asian Pac J Trop Med; 2014 May; 7(5):368-72. PubMed ID: 25063062
[TBL] [Abstract][Full Text] [Related]
15. CSN5 upregulates glycolysis to promote hepatocellular carcinoma metastasis via stabilizing the HK2 protein.
Huang M; Xiong H; Luo D; Xu B; Liu H
Exp Cell Res; 2020 Mar; 388(2):111876. PubMed ID: 31991125
[TBL] [Abstract][Full Text] [Related]
16. Chrysin inhibited tumor glycolysis and induced apoptosis in hepatocellular carcinoma by targeting hexokinase-2.
Xu D; Jin J; Yu H; Zhao Z; Ma D; Zhang C; Jiang H
J Exp Clin Cancer Res; 2017 Mar; 36(1):44. PubMed ID: 28320429
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of FOXK1 suppresses liver cancer cell viability by inhibiting glycolysis.
Cui H; Gao Q; Zhang L; Han F; Wang L
Life Sci; 2018 Nov; 213():66-73. PubMed ID: 30312701
[TBL] [Abstract][Full Text] [Related]
18. Rapamycin regulates the proliferation of Huh7, a hepatocellular carcinoma cell line, by up-regulating p53 expression.
Kwon S; Jeon JS; Ahn C; Sung JS; Choi I
Biochem Biophys Res Commun; 2016 Oct; 479(1):74-9. PubMed ID: 27616194
[TBL] [Abstract][Full Text] [Related]
19. [IL-12 induces autophagy via AKT/mTOR/STAT3 signaling pathway in human hepatoma cells].
Liu C; Xie C; Lin Y; Wu B; Wang Q; Li Z; Tu Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jul; 32(7):870-5. PubMed ID: 27363263
[TBL] [Abstract][Full Text] [Related]
20. STAT3 and beta-catenin signaling pathway may affect GSK-3beta expression in hepatocellular carcinoma.
Wang XH; Meng XW; Xing H; Qu B; Han MZ; Chen J; Fan YJ; Lu CQ; Lu ZW
Hepatogastroenterology; 2011; 58(106):487-91. PubMed ID: 21661417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
